TSHA logo

Taysha Gene Therapies (TSHA) Working Capital

Annual Working Capital

$115.90 M
+$2.79 M+2.47%

December 31, 2024


Summary


Performance

TSHA Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTSHAbalance sheetmetrics:

Quarterly Working Capital

$115.90 M
-$16.32 M-12.34%

December 31, 2024


Summary


Performance

TSHA Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTSHAbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

TSHA Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2.5%+2.5%
3 y3 years+7.5%+7.5%
5 y5 years+10000.0%-

TSHA Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+244.7%-19.7%+1440.8%
5 y5-year-53.8%>+9999.0%-56.7%+1418.4%
alltimeall time-53.8%>+9999.0%-56.7%+1418.4%

Taysha Gene Therapies Working Capital History

DateAnnualQuarterly
Dec 2024
$115.90 M(+2.5%)
$115.90 M(-12.3%)
Sep 2024
-
$132.22 M(-8.4%)
Jun 2024
-
$144.29 M(+56.9%)
Mar 2024
-
$91.96 M(-18.7%)
Dec 2023
$113.11 M(+236.4%)
$113.11 M(-1408.6%)
Sep 2023
-
-$8.64 M(-348.8%)
Jun 2023
-
$3.47 M(-80.6%)
Mar 2023
-
$17.90 M(-46.8%)
Dec 2022
$33.63 M
$33.63 M(+240.9%)
Sep 2022
-
$9.86 M(-70.9%)
DateAnnualQuarterly
Jun 2022
-
$33.88 M(-41.9%)
Mar 2022
-
$58.27 M(-46.0%)
Dec 2021
$107.86 M(-57.0%)
$107.86 M(-29.9%)
Sep 2021
-
$153.96 M(-13.9%)
Jun 2021
-
$178.91 M(-18.9%)
Mar 2021
-
$220.67 M(-12.0%)
Dec 2020
$250.75 M(<-9900.0%)
-
Dec 2020
-
$250.75 M(-6.3%)
Sep 2020
-
$267.61 M(-3144.2%)
Jun 2020
-
-$8.79 M
Dec 2019
-$135.00 K
-

FAQ

  • What is Taysha Gene Therapies annual working capital?
  • What is the all time high annual working capital for Taysha Gene Therapies?
  • What is Taysha Gene Therapies annual working capital year-on-year change?
  • What is Taysha Gene Therapies quarterly working capital?
  • What is the all time high quarterly working capital for Taysha Gene Therapies?
  • What is Taysha Gene Therapies quarterly working capital year-on-year change?

What is Taysha Gene Therapies annual working capital?

The current annual working capital of TSHA is $115.90 M

What is the all time high annual working capital for Taysha Gene Therapies?

Taysha Gene Therapies all-time high annual working capital is $250.75 M

What is Taysha Gene Therapies annual working capital year-on-year change?

Over the past year, TSHA annual working capital has changed by +$2.79 M (+2.47%)

What is Taysha Gene Therapies quarterly working capital?

The current quarterly working capital of TSHA is $115.90 M

What is the all time high quarterly working capital for Taysha Gene Therapies?

Taysha Gene Therapies all-time high quarterly working capital is $267.61 M

What is Taysha Gene Therapies quarterly working capital year-on-year change?

Over the past year, TSHA quarterly working capital has changed by +$2.79 M (+2.47%)